Raised £1.58M from a round supported by Old College Capital, BBI, Scottish Enterprise, EverQuest Capital Partners and existing investors (including Archangels). Funding will support R&D and expansion; company launched msX research-use kits in Boston and appointed Alan Schafer as CTO.
About BIOCAPTIVA
University of Edinburgh spin-out developing the msX magnetic bead platform for preparing blood samples and capturing cell-free DNA to simplify and speed liquid biopsy workflows. Launched msX research kits in the US to serve cancer detection and genomic research.
Edinburgh, United Kingdom
Read Company ProfileFrequently Asked Questions
What type of funding round did BIOCAPTIVA raise?
BIOCAPTIVA raised a seed round.
How much did BIOCAPTIVA raise in its seed?
BIOCAPTIVA raised $1,580,000 GBP in its seed.
Who invested in BIOCAPTIVA's seed?
The investors in BIOCAPTIVA's seed are: Old College Capital, BBI, Scottish Enterprise, EverQuest Capital Partners, Archangels.
What type of investment was BIOCAPTIVA's seed?
BIOCAPTIVA's seed was a equity investment.
How will BIOCAPTIVA use the funds from its seed?
BIOCAPTIVA plans to use the funds for: research and development, expand product range and applications, support growth and scaling, commercial launch (US).